View more in
Science

Phase 1 Trials of Bayer’s Cell and Gene Therapies Enrolling Patients

parkinsonsnewstoday.com
 2021-06-10

Cover picture for the articleA first patient has been dosed in a still-recruiting Phase 1 clinical trial testing DA01, an investigational cell therapy for Parkinson’s disease. A separate Phase 1 trial of a potential gene therapy for Parkinson’s is also recruiting eligible patients in the U.S., according to a press release from Bayer. Parkinson’s...

parkinsonsnewstoday.com

Comments / 0

Comments / 0